Equity
Redeemable NCI
McKesson Redeemable NCI increased by 17.6% to $943M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2026), Redeemable NCI shows a downward trend with a -9.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2026May 8, 2026
How to read this metric
An increase indicates potential future cash obligations to minority shareholders.
Detailed definition
This represents equity interests in subsidiaries held by third parties that have redemption features, allowing the holde...
Peer comparison
Common in companies with complex joint ventures or partially owned subsidiaries.
Metric ID:
redeemable_noncontrolling_interestsHistorical Data
9 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $7M | $0 | $0 | $0 | $0 | $725M | $777M | $802M | $943M |
| QoQ Change | — | -100.0% | — | — | — | — | +7.2% | +3.2% | +17.6% |
Range$0 – $943M
CAGR>999%
Current Streak3+ quarters growth
Redeemable NCI at Other Companies
Frequently Asked Questions
- What is McKesson's redeemable nci?
- McKesson (MCK) reported redeemable nci of $943M in Q1 2026.
- What is the long-term trend for McKesson's redeemable nci?
- Over 3 years (2021 to 2026), McKesson's redeemable nci has grown at a -9.5% compound annual growth rate (CAGR), from $1.27B to $943M.
- What does redeemable nci mean?
- Equity held by others in a subsidiary that the company may be required to buy back.